U.S. market Closed. Opens in 11 hours 30 minutes

BTTX | Better Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/A8.00K18.00K
Cost of Revenue2.73M1.62M682.00K898.00K
Gross Profit-2.73M-1.62M-674.00K-880.00K
Operating Expenses38.26M30.56M5.65M4.89M
Selling, General & Admin21.82M11.12M2.67M2.60M
Research & Development16.44M19.44M2.98M2.29M
Other Operating ExpensesN/AN/AN/AN/A
Operating Income-38.26M-30.56M-6.32M-5.77M
Other Expenses / Income-1.49M-9.93M89.00K-11.00K
Before Tax Income-39.75M-40.49M-6.23M-5.78M
Income Tax Expenses7.00K-153.00K153.00K11.00K
Net Income-39.76M-40.34M-6.39M-5.79M
Interest Expenses1.49M185.00K100.00K11.00K
Basic Shares Outstanding23.56M23.60M7.56M23.60M
Diluted Shares Outstanding23.56M23.60M7.56M23.60M
EBITDA-38.26M-30.56M-6.25M-5.70M
EBITDA Margin0.00%0.00%-78,100.00%-31,672.22%
EBIT-38.26M-40.30M-6.13M-5.77M
EBIT Margin0.00%0.00%-76,675.00%-32,072.22%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙